Anavex Life Sciences
AVXL
#7772
Rank
โ‚ฌ0.29 B
Marketcap
3,25ย โ‚ฌ
Share price
-2.68%
Change (1 day)
-62.92%
Change (1 year)

Anavex Life Sciences (AVXL) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ80.92 Million

According to Anavex Life Sciences 's latest financial reports the company has โ‚ฌ80.92 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Anavex Life Sciences - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$โ‚ฌ0.10 B-19.41%
2023-09-30$โ‚ฌ0.13 B-7.99%
2022-09-30$โ‚ฌ0.14 B11.77%
2021-09-30$โ‚ฌ0.13 B460.99%
2020-09-30$โ‚ฌ23.22 M24.78%
2019-09-30$โ‚ฌ18.61 M-3.22%
2018-09-30$โ‚ฌ19.23 M-6.89%
2017-09-30$โ‚ฌ20.65 M267.02%
2016-09-30$โ‚ฌ5.62 M-50.91%
2015-09-30$โ‚ฌ11.46 M7416.46%
2014-09-30$โ‚ฌ0.15 M-108.38%
2013-09-30$-โ‚ฌ1.83 Million-18.86%
2012-09-30$-โ‚ฌ2.25 Million166.67%
2011-09-30$-โ‚ฌ0.85 Million-61.27%
2010-09-30$-โ‚ฌ2.18 Million-18.23%
2009-09-30$-โ‚ฌ2.66 Million62.51%
2008-09-30$-โ‚ฌ1.64 Million403.38%
2007-09-30$-โ‚ฌ0.33 Million2551.77%
2006-09-30$-โ‚ฌ0.02 Million-43.42%
2005-09-30$-โ‚ฌ0.03 Million-204.98%
2004-09-30$โ‚ฌ0.02 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ0.81 B 901.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ0.34 Billion-508.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚ฌ0.53 B 566.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ0.33 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA